Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real‐world experience
Abstract Purpose The aim of this study was to investigate the factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment. Methods We conducted a retrospective study using a multi‐institutional electronic medical records database in Taiwan. We...
Main Authors: | Po‐Ting Lin, Min‐Hua Hung, Shih‐Chieh Shao, Hui‐Yu Chen, Yuk‐Ying Chan, Kai‐Cheng Chang, Shi‐Ming Lin, Huang‐Tz Ou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6124 |
Similar Items
-
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
by: Gilabert M, et al.
Published: (2018-11-01) -
Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence
by: De Luca E, et al.
Published: (2020-05-01) -
Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
by: Naoya Kanogawa, et al.
Published: (2023-03-01) -
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
by: Chia-Jui Yen, et al.
Published: (2020-05-01) -
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
by: James J. Harding, et al.
Published: (2021-05-01)